Manhattan BioSolutions

Manhattan BioSolutions, Inc. is a private biotechnology company focused on developing bio-immunotherapies targeting host defense pathways for the treatment of advanced cancers. The company has developed two drug discovery technology platforms through collaborations with leading academic institutions: RNA degradation proteins and antibody-drug conjugates (ADCs).